Implement pharmaceutical serialisation and track-and-trace systems compliant with EU FMD, US DSCSA, and other global regulations. Covers unique identifier generation, aggregation hierarchy, EPCIS data exchange, and verification endpoint integration. Use when implementing serialisation for a new product launch, integrating with the EMVS/NMVS, designing DSCSA-compliant transaction exchange, building an EPCIS event repository, or extending serialisation to additional markets (China, Brazil, Russia).
日本語の概要は準備中です。原文の説明を表示しています。
pjt222/agent-almanac☆ 372026年10月10日 更新
Map the intellectual property landscape for a technology domain or product area. Covers patent cluster analysis, white space identification, competitor IP portfolio assessment, freedom-to-operate preliminary screening, and strategic IP positioning recommendations. Use before starting R&D in a new technology area, when evaluating market entry against incumbents with strong patent portfolios, preparing for investment due diligence, informing a patent filing strategy, or assessing freedom-to-operate risk for a new product.
日本語の概要は準備中です。原文の説明を表示しています。
pjt222/agent-almanac☆ 372026年10月10日 更新
Estimates SNP heritability and partitions it across functional annotations, cell types, and loci from GWAS summary statistics or individual-level genotypes. Implements LDSC, stratified LDSC with the baseline-LD model, Finucane 2018 cell-type prioritization, LDAK SumHer, HDL, HESS local heritability, BOLT-REML, GCTA-GREML, graphREML, and Popcorn cross-population genetic correlation. Use when computing total h2_SNP from summary stats, partitioning heritability across functional categories, prioritizing trait-relevant tissues or cell types from ENCODE/Roadmap chromatin marks, reconciling LDSC vs LDAK enrichment estimates, computing local heritability with HESS, estimating genetic correlation between traits, or producing publication-grade enrichment with calibrated sensitivity to model assumptions.
日本語の概要は準備中です。原文の説明を表示しています。
lilinji/GeneTind-Life-Skills☆ 142026年8月21日 更新
Map the competitive landscape for a Stellar project idea. Use when a user says "who are my competitors on Stellar", "competitive analysis Stellar", "what already exists in this space on Stellar", "show me similar Stellar projects", "is anyone else building this on Stellar", or "map the Stellar landscape for X". Queries the 728-project LumenLoop ecosystem database and Electric Capital developer activity to rank competitors by SCF funding history and repo activity.
日本語の概要は準備中です。原文の説明を表示しています。
stellar-zk/stellar-zk☆ 42026年10月10日 更新
Estimate SNP heritability and partition it across functional annotations, cell types, and loci from GWAS summary statistics or individual-level genotypes. Implements LDSC, stratified LDSC with the baseline-LD model, Finucane 2018 cell-type prioritization, LDAK SumHer, HDL, HESS local heritability, BOLT-REML, GCTA-GREML, graphREML, and Popcorn cross-population genetic correlation. Use when computing total h2_SNP from summary stats, partitioning heritability across functional categories, prioritizing trait-relevant tissues or cell types from ENCODE/Roadmap chromatin marks, reconciling LDSC vs LDAK enrichment estimates, computing local heritability with HESS, estimating genetic correlation between traits, or producing publication-grade enrichment with calibrated sensitivity to model assumptions.
日本語の概要は準備中です。原文の説明を表示しています。
peacezha/HPClaw☆ 32026年10月11日 更新
Deep competitive intelligence for any market. Analyzes competitors' products, pricing, customer sentiment, GTM strategy, and growth signals using real web data. Produces battle cards, pricing landscape, and feature matrix. Use when the user wants to understand their competitive landscape, analyze competitors, compare products in a market, or research who they're competing against. Triggers for "who are my competitors", "competitive analysis", "competitor research", "battle cards", "pricing comparison", "competitor pricing", "market players", "competitive intelligence", "competitive landscape", "who else is in this space", "competitive moat", or any request to profile, compare, or map competitors in a category. Works standalone — no prior startup-design session needed.
日本語の概要は準備中です。原文の説明を表示しています。
sathishssj3/Stereix-Engine☆ 22026年10月4日 更新
採点済みの競合情報を、市場マップや比較表、差別化の余地、優先施策を含むレポートにまとめます。経営層への報告や、チームで競争方針を決める場面に役立ちます。
- 経営層や取締役会向けの競合報告
- 完成済み競合プロフィールの統合
- 差別化の余地と競合脅威の検討
affaan-m/ECC☆ 27.8万2026年10月12日 更新
自社の強みや顧客像を基に、比較すべき競合と調査先を選びます。直接競合・周辺競合・目標となる企業に分類し、根拠付きの候補一覧を作って詳しい比較の準備を整えます。
- 競合比較の対象を決めたいとき
- 直接競合・周辺競合・目標企業の分類
- 市場調査レポートの候補を絞りたいとき
affaan-m/ECC☆ 27.8万2026年10月12日 更新
Create comprehensive industry and sector landscape reports covering market dynamics, competitive positioning, key players, and thematic trends. Use for client requests, sector initiations, thematic research pieces, or internal knowledge building. Triggers on "sector overview", "industry report", "market landscape", "sector analysis", "industry deep dive", or "thematic research".
日本語の概要は準備中です。原文の説明を表示しています。
anthropics/financial-services☆ 4万2026年9月22日 更新
Framework for building competitive landscape decks — market positioning, competitor deep-dives, comparative analysis, strategic synthesis. Use when the user asks for a competitive landscape, competitor analysis, peer comparison, market positioning assessment, strategic review, or investment memo deck. Also triggers on "who are the competitors to X", "benchmark X against peers", "build a market map", or any request to systematically evaluate competitive dynamics across an industry.
日本語の概要は準備中です。原文の説明を表示しています。
anthropics/financial-services☆ 4万2026年9月22日 更新
Deploys and configures Tailscale (or self-hosted Headscale) as a WireGuard-based zero trust mesh VPN, setting up identity-aware ACLs, exit nodes, subnet routers, and MagicDNS for encrypted peer-to-peer connectivity. Use when replacing traditional VPN servers with an identity-authenticated mesh network or enforcing granular per-device access control lists.
日本語の概要は準備中です。原文の説明を表示しています。
mukul975/Anthropic-Cybersecurity-Skills☆ 3.4万2026年8月31日 更新
Build a live Three.js landscape that stays quiet behind a subject — a noise heightfield on a polar grid so resolution follows the lens, ground coloured by slope and moisture rather than by texture, instanced GPU grass whose wind costs nothing on the CPU, scattered stones, a gradient sky dome, a star field you can actually see, and a time-of-day system that cross-fades instead of cutting. Use for hero backdrops, product stages, scroll worlds, or any scene where a building, object, or figure has to sit in a place rather than float on a gradient.
日本語の概要は準備中です。原文の説明を表示しています。
MengTo/Skills☆ 6,7222026年10月6日 更新
Scans the biomarker landscape of a disease area by biomarker type, clinical/research use case, evidence layer, validation status, and maturity level. Use this skill when a user wants a field-level biomarker evidence map rather than a generic literature summary. Always separate exploratory biomarkers from externally validated or clinically embedded biomarkers, and never imply clinical maturity without explicit evidence support.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9422026年9月17日 更新
Rapidly maps the evidence landscape around a medical topic by organizing major research streams, target populations, endpoints, methods, evidence density, and thin areas. Use this skill BEFORE medical-research-gap-finder — it provides the structured landscape that makes formal gap analysis more rigorous. Do not use for formal gap identification, study design, or protocol planning directly.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9422026年9月17日 更新
Organizes the evidence and competitive landscape around a drug, target, or pathway by separating disease relevance, tractability, preclinical evidence, clinical evidence, modality fit, and crowding. Always map what is biologically supported, what is druggable, what has actually advanced, and what remains strategically open. Never confuse target relevance with druggability, preclinical activity with clinical promise, or narrative excitement with validated development maturity. Never fabricate references, trial status, approval status, company activity, or asset metadata.
日本語の概要は準備中です。原文の説明を表示しています。
aipoch/medical-research-skills☆ 1,9422026年9月17日 更新
This skill should be used when the user asks to "analyze competitors", "assess competitive landscape", "identify differentiation", "evaluate market positioning", "apply Porter's Five Forces", or requests competitive strategy analysis.
日本語の概要は準備中です。原文の説明を表示しています。
rmyndharis/antigravity-skills☆ 1,7412026年10月1日 更新
Für Vereinsbedingungen: ordnet Norm, Beweislast und Gegenargument; Ergebnis: Prüfprodukt mit Risiko und nächstem Schritt. Fachgebiet: AGB-Recht-Prüfer. Route: agb-vereinsbedingungen-mitgliedschaft.
日本語の概要は準備中です。原文の説明を表示しています。
Klotzkette/claude-fuer-deutsches-recht☆ 1,6932026年10月11日 更新
Use C#/.NET in Godot 4.7: partial classes extending nodes, the PascalCase lifecycle (_Ready/_Process/_PhysicsProcess), [Export] fields, [Signal] delegates as C# events, type-safe node lookup, and calling between C# and GDScript. Use when writing Godot game code in C# (.cs files, .csproj), needing the Godot .NET build, converting GDScript patterns to C#, or wiring Godot signals as C# events.
日本語の概要は準備中です。原文の説明を表示しています。
gamedev-skills/awesome-gamedev-agent-skills☆ 1,4452026年10月9日 更新
Run GDScript test suites from the command line with `godot --headless`, using a SceneTree/MainLoop runner script that exits non-zero on failure so CI can gate merges. Use when a Godot project needs unit tests without opening the editor, when wiring a CI job (GitHub Actions or similar) that must fail the build on a failing `.gd` test, or when a `godot --headless` invocation hangs, opens a window, or exits 0 despite failed assertions.
日本語の概要は準備中です。原文の説明を表示しています。
gamedev-skills/awesome-gamedev-agent-skills☆ 1,4452026年10月9日 更新
Monitor competitor signals and surface strategic implications for your roadmap. Use when asked to monitor competitors, track the competitive landscape, produce a competitive briefing, or understand what has changed in the market this week or month. Produces a structured intelligence brief with high/medium/low priority signals, roadmap implications, and a strategic landscape summary. For a single competitor announcement use competitor-signal-tracker; for a one-off deep dive use competitor-teardown.
日本語の概要は準備中です。原文の説明を表示しています。
mohitagw15856/pm-claude-skills☆ 1,4402026年10月12日 更新
Analyze competitors and create competitive landscape documentation with feature matrices, positioning maps, and strategic recommendations. Use when asked to analyze competitors, create competitive analysis, compare features with competitors, build a competitive landscape, track competitive positioning, or prepare sales battlecard inputs. Produces structured competitor profiles, feature comparison matrix, win/loss analysis, and prioritised strategic recommendations. For a one-off teardown of a single rival use competitor-teardown; for a recurring market briefing use competitive-intelligence-monitor.
日本語の概要は準備中です。原文の説明を表示しています。
mohitagw15856/pm-claude-skills☆ 1,4402026年10月12日 更新
Tests genotype-environment associations and identifies adaptive loci while correcting for the four-confound landscape (structure, demography, background selection, sampling design) using LFMM2 with mandatory K via sNMF cross-entropy elbow (LEA 3), BayPass Core/AUX/C2/IS with Omega covariance matrix, RDA / pRDA for polygenic adaptation (Forester 2018; requires imputed genotypes), OutFLANK with trimmed FST null, pcadapt, gradient forests (Ellis-Smith-Pitcher 2012, NOT mis-cited Ellis-Manel), Capblancq & Forester 2021 RDA Swiss-army-knife, genomic-offset prediction with Lind & Lotterhos 2025 three-regime caveat, Lotterhos-Whitlock sampling optima, Wang & Bradburd 2014 IBD vs IBE, and Circuitscape + ResistanceGA. Use when identifying adaptive loci across gradients, choosing K for LFMM2, deciding among GEA methods, predicting maladaptation with the novel-environment caveat, distinguishing IBD vs IBE, or optimizing sampling design.
日本語の概要は準備中です。原文の説明を表示しています。
GPTomics/bioSkills☆ 1,2192026年8月15日 更新
Estimates bivariate genetic correlation (rg) between traits from GWAS summary statistics or individual-level genotypes using cross-trait LDSC, HDL, LAVA, rho-HESS, GREML-bivariate, Popcorn, and HDL-L. Use when quantifying shared genetic architecture between two traits, screening MR validity before causal inference, distinguishing global from locus-level rg, estimating trans-ancestry rg, separating partial from full causation via LCV gcp, or producing a STROBE-MR-compliant cross-trait sensitivity battery. Cross-trait LDSC intercept absorbs sample overlap and is NOT a bias; HDL is biased under sample overlap above ~5%. High rg between exposure and outcome motivates CHP-aware MR sensitivity (CAUSE, LHC-MR).
日本語の概要は準備中です。原文の説明を表示しています。
GPTomics/bioSkills☆ 1,2192026年8月15日 更新
Analyze current trends and challenges in Japanese NLP for a topic. Surveys the existing awesome-japanese-nlp-resources dataset and augments it with up-to-the-minute web research to produce a combined trend + issue report. Use only when the user explicitly wants a trend/landscape report, a challenges/limitations report, or a general research overview of a Japanese NLP topic (this combines the bundled dataset with live web research). Trigger phrases include '日本語LLMの最新トレンド', '〜の動向をまとめて', '最近の日本語NLPの流れ', '日本語LLMの課題', '〜の問題点・限界', '未解決の論点', 'trend report on Japanese embeddings', 'latest Japanese speech models', 'challenges in Japanese NER', 'limitations of Japanese embeddings'. For a simple lookup use the search skill; this one runs web research.
taishi-i/awesome-japanese-nlp-resources☆ 1,0212026年10月6日 更新